The Transitions Project: Efficacy Trial
The aim of this study is to evaluate the efficacy of a brief psychoeducational intervention to improve quality of life in patients with lung cancer who are transitioning from active treatment to surveillance.
Checked against the public recordLast updated Mar 30, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Massachusetts General Hospital
- Interventions being studied
- Behavioral: Five Psycho-educational Session(s); Behavioral: One Psycho-educational Session(s)
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Age 21 or older * Able to read and respond in English * Diagnosis of non-small cell lung cancer or small cell lung cancer * Documented curative treatment plan including systemic therapy +/- radiation and +/- surgery * Completed cancer treatment within past 3 weeks * If final treatment is systemic therapy +/- radiation: within 3 weeks after cancer care team determination that treatment is complete * If final treatment is surgery: within 3 weeks after hospital discharge following surgery Exclusion Criteria: * Comorbid health condition that would interfere with study participation * Current participation in cognitive behavioral therapy treatment
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Massachusetts General Hospital Cancer CenterBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 30, 2026. Always confirm current availability with the study team.